In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-24 of 24 for your search:
Cancer Type/Condition:  Myelodysplastic syndromes
Stage/Subtype:  childhood myelodysplastic syndromes
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P30CA015704, P01CA018029, NCT01231412

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 55
Sponsor: NCI, Other
Protocol IDs: 06-125, MSKCC-06125, NCT00423514

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 2230.00, NCI-2010-00106, P30CA015704, P01CA078902, FHCRC-2230.00, IR-6771, NCT00789776

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 13 to 60
Sponsor: NCI, Other
Protocol IDs: BMT236, SU-09142011-8407, NCT01660607

5.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1825.00, NCI-2010-00230, P30CA015704, P01CA078902, FHCRC-1825.00, 5605, SUPERGEN-FHCRC-1825.00, NCT00096161

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 2056.00, NCI-2010-00237, P30CA015704, P01CA018029, FHCRC-2056.00, 6171, NCT00397813

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 6 months to 45 years
Sponsor: NCI, Other
Protocol IDs: 2010.00, NCI-2010-00190, P30CA015704, FHCRC-2010.00, 6095, NCT00719888

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 2239.00, NCI-2009-01551, P30CA015704, FHCRC-2239.00, 6722, FHCRC-IR-6722, NCT00723099

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 65
Sponsor: NCI, Other
Protocol IDs: 2275.00, NCI-2010-00299, P30CA015704, FHCRC-2275.00, IR-6800, NCT00796068

10.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 14 to 55
Sponsor: NCI, Other
Protocol IDs: FHCRC-2222.00, P30CA015704, P01CA018029, IR-6907, CDR0000644201, 0903004832, NCT00914940

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 75 and under
Sponsor: NCI, Other
Protocol IDs: 2212.00, NCI-2009-01244, P30CA015704, U19AI096111, P01CA018029, NCT00968630

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 0 to 75
Sponsor: NCI, Other
Protocol IDs: 2241.00, NCI-2009-01334, P30CA015704, P01CA078902, NCT01008462

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2206.00, NCI-2010-02222, P30CA015704, P01CA018029, NCT01251575

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 9 to 40
Sponsor: NCI
Protocol IDs: 110136, 11-C-0136, NCT01338987

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 15 and over
Sponsor: NCI, Other
Protocol IDs: 710, U01HL069294, BMT CTN 0903, NCT01410344

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 14 to 75
Sponsor: NCI, Other
Protocol IDs: 12-1191, NCI-2013-00782, NCT01839916

17.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, NHLBI
Protocol IDs: 130116, 13-H-0116, NCT01861093

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 6 to 70
Sponsor: NCI
Protocol IDs: 130132, 13-C-0132, NCT01861106

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 2524.00, NCI-2013-01261, P30CA015704, K12HL087165, NCT01894477

20.

Phase: Phase I
Type: Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000491633, DFCI-05030, MDA-2005-0695, NCT00376480

21.

Phase: Phase I
Type: Treatment
Status: Active
Age: 31 and under
Sponsor: NCI, Other
Protocol IDs: RELHEM, R01CA138744, NCT00908167

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL1011, COG-ADVL1011, NCT01164163

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE9Z13, NCI-2014-00837, P30CA043703, NCT02129582

24.

Phase: No phase specified
Type: Treatment
Status: Active
Age: Under 65
Sponsor: NCI, Other
Protocol IDs: 1410.00, NCI-2010-00802, P30CA015704, P01CA018029, FHCRC-1410.00, NCT00112593
New Search